Validation of Prognostic Circulating Cell-Free RNA Biomarkers HPGD, PACS1, and TDP2 in Colorectal Cancer Through TaqMan qPCR and Correlation Analysis.

Curr Issues Mol Biol · 2025 · PMC12293443 · PMID 40728977

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

Figure 6 emphasizes the relationship between the TDP2 ΔCT post-operation and the recurrence, where data points primarily aggregate around 3–4 for non-recurrent cases, with a notable increase towards ΔCT values of 6–7 for recurrent cases, indicating a significant trend.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Validation of Prognostic Circulating Cell-Free RNA Biomarkers &lt;i&gt;HPGD&lt;/i&gt;, &lt;i&gt;PACS1&lt;/i&gt;, and &lt;i&gt;TDP2&lt;/i&gt; in Colorectal Cancer Through TaqMan qPCR and Correlation Analysis.

The sentences

Validation of Prognostic Circulating Cell-Free RNA Biomarkers <i>HPGD</i>, <i>PACS1</i>, and <i>TDP2</i> in Colorectal Cancer Through TaqMan qPCR and Correlation Analysis.